Women have historically been underrepresented in Phase I and II clinical trials, including areas of research such as Alzheimer’s and autoimmune diseases in which women are more affected. This results in drugs being tailored for men, which leads to a higher rate of women experiencing adverse effects of these drugs than men. Medical testing needs to involve women at every stage to prevent these inequalities from occurring and to prioritize women’s health.
View More Sex-Based Bias in Medical Research is Dangerous
